Literature DB >> 9540019

Neuropsychological complications of IDDM in children 2 years after disease onset.

E A Northam1, P J Anderson, G A Werther, G L Warne, R G Adler, D Andrewes.   

Abstract

OBJECTIVE: To compare the neuropsychological profiles of children with IDDM with a community control group at two time points: 3 months after disease onset and 2 years after the baseline assessment. RESEARCH DESIGN AND METHODS: A total of 123 children (age 3-14 years) with recent IDDM onset were compared with 129 community control subjects, stratified for age and sex, on standardized measures of general intelligence, attention, speed of processing, memory, learning, executive skills, and behavioral adjustment soon after diagnosis and 2 years later. Exclusion criteria were premorbid evidence of central nervous system disease or trauma, or English not spoken in the home.
RESULTS: There were no differences between children with IDDM and control subjects on any measure at the initial assessment 3 months after disease onset. Two years later, children with IDDM tended to show a less positive change, relative to control subjects, in their standardized scores on measures of general intelligence, and significantly so on the vocabulary (P < 0.01) and block design (P < 0.05) subtests. Multivariate group differences were also apparent on speed of processing (P < 0.05) and learning (P < 0.01) subtests, reflecting smaller developmental gains in the children with IDDM when compared with control subjects.
CONCLUSIONS: The findings are consistent with previous reports, suggesting that IDDM is associated with an increased risk of mild neuropsychological dysfunction. The skills most affected in this cohort were information processing speed, acquisition of new knowledge, and conceptual reasoning abilities. Clinicians and educators should be made aware of the risk of specific neuropsychological deficits in children with IDDM.

Entities:  

Mesh:

Year:  1998        PMID: 9540019     DOI: 10.2337/diacare.21.3.379

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  28 in total

1.  Neurocognitive functioning in preschool-age children with type 1 diabetes mellitus.

Authors:  Anna Maria Patiño-Fernández; Alan M Delamater; E Brooks Applegate; Erika Brady; Margaret Eidson; Robin Nemery; Luis Gonzalez-Mendoza; Samuel Richton
Journal:  Pediatr Diabetes       Date:  2010-04-23       Impact factor: 4.866

Review 2.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

3.  Standards of medical care in diabetes--2011.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

4.  Longitudinal Evaluation of Cognitive Functioning in Young Children with Type 1 Diabetes over 18 Months.

Authors:  M Allison Cato; Nelly Mauras; Paul Mazaika; Craig Kollman; Peiyao Cheng; Tandy Aye; Jodie Ambrosino; Roy W Beck; Katrina J Ruedy; Allan L Reiss; Michael Tansey; Neil H White; Tamara Hershey
Journal:  J Int Neuropsychol Soc       Date:  2016-01-20       Impact factor: 2.892

5.  Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function.

Authors:  Christopher T Kodl; Daniel T Franc; Jyothi P Rao; Fiona S Anderson; William Thomas; Bryon A Mueller; Kelvin O Lim; Elizabeth R Seaquist
Journal:  Diabetes       Date:  2008-08-11       Impact factor: 9.461

6.  Standards of medical care in diabetes--2009.

Authors: 
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

7.  Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

Review 8.  The Relationship Between Executive Functioning, Type 1 Diabetes Self-Management Behaviors, and Glycemic Control in Adolescents and Young Adults.

Authors:  Ke Ding; Cheyenne M Reynolds; Kimberly A Driscoll; David M Janicke
Journal:  Curr Diab Rep       Date:  2021-02-22       Impact factor: 4.810

9.  Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with type 1 diabetes mellitus: a pilot study.

Authors:  S Knight; E Northam; S Donath; A Gardner; N Harkin; C Taplin; P Joy; F J Cameron; G R Ambler
Journal:  Diabetologia       Date:  2008-11-06       Impact factor: 10.122

10.  A longitudinal investigation of cognitive function in children and adolescents with type 1 diabetes mellitus.

Authors:  Brenda A Kirchhoff; Dustin K Jundt; Tasha Doty; Tamara Hershey
Journal:  Pediatr Diabetes       Date:  2016-07-22       Impact factor: 4.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.